Page last updated: 2024-08-21

paraoxon and Absence Status

paraoxon has been researched along with Absence Status in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	7 (70.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Bar-Klein, G; Eisenkraft, A; Friedman, A; Kamintsky, L; Prager, O; Rosman, Y; Serlin, Y; Shrot, S; Statlender, L; Swissa, E; Weissberg, I	1
Blair, RE; DeLorenzo, RJ; Deshpande, LS; Halquist, M; Kosmider, L	1
Chapman, J; Eisenkraft, A; Gera, O; Golderman, V; Maggio, N; Shavit-Stein, E	1
Bar-Klein, G; Chai, O; Elkin, M; Friedman, A; Hanael, E; Kaufer, D; Konstantin, L; Peery, D; Senatorov, VV; Shamir, MH; Veksler, R	1
Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Phillips, KF	1
Bar-Klein, G; Biala, Y; Daninos, M; Friedman, A; Kamintsky, L; Kassirer, M; Krivoy, A; Lavon, O; Makarovsky, I; Ramaty, E; Rosman, Y; Shrot, S; Statlender, L; Yaari, Y	1
Bar-Klein, G; Bialer, M; Eisenkraft, A; Friedman, A; Hubary, Y; Kamintsky, L; Saar-Ashkenazy, R; Shekh-Ahmad, T; Shrot, S; Stetlander, L; Swissa, E	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Krishnan, JK; Miller, SL; Pidoplichko, VI	1
Balint, CA; Cowan, ML; Kapur, J; Sun, C; Todorovic, MS	1
Goodkin, HR; Joshi, S; Kapur, J; Kozhemyakin, M	1

Trials

1 trial(s) available for paraoxon and Absence Status

Article	Year
Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging. Epilepsia, 2019, Volume: 60, Issue:5 Topics: Albumins; Algorithms; Animals; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Convulsants; Dog Diseases; Dogs; Epilepsy; Gliosis; Magnetic Resonance Imaging; Neuroimaging; Paraoxon; Piriform Cortex; Prospective Studies; Rats; Serum Albumin; Signal Transduction; Status Epilepticus; Transforming Growth Factor beta	2019

Article

Year

Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging.

Epilepsia, 2019, Volume: 60, Issue:5

Topics: Albumins; Algorithms; Animals; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Convulsants; Dog Diseases; Dogs; Epilepsy; Gliosis; Magnetic Resonance Imaging; Neuroimaging; Paraoxon; Piriform Cortex; Prospective Studies; Rats; Serum Albumin; Signal Transduction; Status Epilepticus; Transforming Growth Factor beta

2019

Other Studies

9 other study(ies) available for paraoxon and Absence Status

Article	Year
Midazolam and isoflurane combination reduces late brain damage in the paraoxon-induced status epilepticus rat model. Neurotoxicology, 2020, Volume: 78 Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Isoflurane; Male; Midazolam; Paraoxon; Rats, Sprague-Dawley; Status Epilepticus	2020
Intramuscular atenolol and levetiracetam reduce mortality in a rat model of paraoxon-induced status epilepticus. Annals of the New York Academy of Sciences, 2020, Volume: 1480, Issue:1 Topics: Administration, Oral; Animals; Atenolol; Injections, Intramuscular; Levetiracetam; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Status Epilepticus	2020
Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus. Journal of molecular neuroscience : MN, 2019, Volume: 67, Issue:2 Topics: Animals; Cholinesterase Inhibitors; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Paraoxon; Prothrombin; Receptors, Thrombin; Status Epilepticus	2019
Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication. Neurotoxicology, 2014, Volume: 44 Topics: Animals; Anticonvulsants; Atropine; Brain; Calcium; Diazepam; Disease Models, Animal; Electroencephalography; Hippocampus; Male; Neurons; Organophosphate Poisoning; Paraoxon; Pralidoxime Compounds; Rats; Rats, Sprague-Dawley; Status Epilepticus	2014
Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment. Toxicology, 2014, Sep-02, Volume: 323 Topics: Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Chronic Disease; Epilepsy; Midazolam; Muscarinic Agonists; Obidoxime Chloride; Paraoxon; Pesticides; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus	2014
sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats. Epilepsia, 2014, Volume: 55, Issue:12 Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Insecticides; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Status Epilepticus; Stereoisomerism; Treatment Outcome; Valproic Acid	2014
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala. The Journal of pharmacology and experimental therapeutics, 2017, Volume: 360, Issue:1 Topics: Animals; Basolateral Nuclear Complex; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Soman; Status Epilepticus; Sulfonamides; Synapses; Thiadiazoles	2017
Characterization of status epilepticus induced by two organophosphates in rats. Epilepsy research, 2012, Volume: 101, Issue:3 Topics: Animals; Anticonvulsants; Atropine; Brain; Diazepam; Electroencephalography; Isoflurophate; Male; Neurons; Paraoxon; Rats; Rats, Sprague-Dawley; Seizures; Status Epilepticus	2012
Impact of receptor changes on treatment of status epilepticus. Epilepsia, 2007, Volume: 48 Suppl 8 Topics: Action Potentials; Animals; Benzodiazepines; Cholinesterase Inhibitors; Disease Models, Animal; Drug Resistance; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Humans; Male; Paraoxon; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Status Epilepticus; Synaptic Transmission	2007